The cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 3751-3761

  Thompson, Peter ^a   Lu, Jinhua ^a   Kaplan, Gerardo G ^a,b  

^a Center for Biologics Evaluation/Res   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; MONOCLONAL ANTIBODY; TUNICAMYCIN; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ARTICLE; CERCOPITHECIDAE; DOG; ESCHERICHIA COLI; GENE DELETION; HEPATITIS A VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RECEPTOR BINDING; SEQUENCE HOMOLOGY;

EID: 0031958415     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.3751-3761.1998     Document Type: Article

References (23)

1. Ashida, M., and C. Hamada. 1997. Molecular cloning of the hepatitis A virus receptor from a simian cell line. J. Gen. Virol. 78:1565-1569.
2. Bishop, N. E., and D. A. Anderson. 1993. RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus. Virology 197:616-623.
3. Cohen, J. I., J. R. Ticehurst, S. M. Feinstone, B. Rosenblum, and R. H. Purcell. 1987. Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J. Virol. 61:3035-3039.
4. Dotzauer, A., S. M. Feinstone, and G. Kaplan. 1994. Susceptibility of non-primate cell lines to hepatitis A virus infection, J. Virol. 68:6064-6068.
5. Gauss-Muller, V., F. Lottspeich, and F. Deinhardt. 1986. Characterization of hepatitis A virus structural proteins. Virology 155:732-736.
6. Innis, B. L., R. Snitbhan, P. Kunasol, T. Laorakpongse, W. Poopatanakool, C. A. Kozik, S. Suntayakorn, T. Suknuntapong, A. Safary, D. B. Tang, et al. 1994. Protection against hepatitis A by an inactivated vaccine. JAMA 271: 1328-1334.
7. Jentoft, N. 1990. Why are proteins O-glysylated? Trends Biochem. Sci. 15: 291-294.
8. Jia, X. Y., D. F. Summers, and E. Ehrenfeld. 1993. Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology 193:515-519.
9. Jia, X. Y., M. Tesar, D. F. Summers, and E. Ehrenfeld. 1996. Replication of hepatitis A viruses with chimeric 5′ nontranslated regions. J. Virol. 70:2861-2868.
10. Kaplan, G., A. Totsuka, P. Thompson, T. Akatsuka, Y. Moritsugu, and S. M. Feinstone. 1996. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 15:4282-4296.
11. Karnauchow, T. M., D. L. Tolson, B. A. Harrison, F. Altman, D. M. Lublin, and K. Dimock. 1996. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70:5143-5152.
12. Kusov, Y., Y. A. Kazachkov, G. K. Dzagurov, G. A. Khozinskaya, M. S. Balayan, and V. Gauss-Muller. 1992. Identification of precursors of structural proteins VP1 and VP2 of hepatitis A virus. J. Med. Virol. 37:220-227.
13. Maisner, A., J. Alvarez, M. K. Liszewski, D. J. Atkinson, J. P. Atkinson, and G. Herrler. 1996. The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor. J. Virol. 70:4973-4977.
14. Maisner, A., J. Scheneider-Schaulies, M. K. Liszewski, J. P. Atkinson, and G. Herrler. 1994. Binding of measles virus to membrane cofactor protein (CD46): importance of disulfide bonds and N-glycans for the receptor function. J. Virol. 68:6299-6304.
15. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
16. Murphy, A. J. M., A. L. Kung, R. A. Swirski, and R. T. Schimke. 1992. cDNA expression cloning in human cells using the pλDR2 episomal vector system. Methods (Orlando) 4:111-131.
17. Schultheiss, T., W. Sommergruber, Y. Kusov, and V. Gauss-Muller. 1995. Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates. J. Virol. 69:1727-1733.
18. Swirski, R. A., D. Van Den Berg, A. J. M. Murphy, C. M. Lambert, E. C. Friedberg, and R. T. Schimke. 1992. Improvements in the Epstein-Barr-based shuttle vector system for direct cloning in human tissue culture cells. Methods (Orlando) 4:133-142.
19. Tesar, M., X. Y. Jia, D. F. Summers, and E. Ehrenfeld. 1993. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology 194:616-626.
20. Totsuka, A., and Y. Moritsugu. 1994. Hepatitis A vaccine development in Japan, p. 509-513. In K. Nishioka, H. Suzuki, S. Mishiro, and T. Oda (ed.), Viral hepatitis and liver disease. Springer-Verlag, Tokyo, Japan.
21. Weitz, M., B. M. Baroudy, W. L. Maloy, J. R. Ticehurst, and R. H. Purcell. 1986. Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J. Virol. 60:124-130.
22. Werzberger, A., B. Mensch, B. Kuter, L. Brown, J. Lewis, R. Sitrin, W. Miller, D. Shouval, B. Wiens, G. Calandra, et al. 1992. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N. Engl. J. Med. 327:453-457.
23. Wimmer, E. (ed.). 1994. Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.